Home » Six Facility of the Year Awards Winners Announced for 2013
Six Facility of the Year Awards Winners Announced for 2013
The Facility of the Year Awards (FOYA) judging panel has selected six Category Award Winners in the 2013 Facility of the Year Awards program. The winning projects were chosen from 27 entries and are located in Ireland, Switzerland, the United Kingdom and the United States.
"The FOYA program is about recognizing the pharmaceutical industry's innovation and technical advances in facility manufacturing, which ultimately is about helping patients who need and depend upon us for a reliable supply of quality medications," said Chaz Calitri, Vice President of Network Performance at Pfizer and chair of the 2013 FOYA Judging Panel. "The six facilities honored by this year's awards program embody innovation, exemplified by advances in areas including flu vaccine manufacturing, which is very relevant in parts of the world right now where outbreaks have occurred, threatening public health. All of this year's honorees are to be commended for their important contributions to our industry and, most importantly, to improving people's lives."
The winners and their award categories are as follows:
1. Biogen Idec, winner of the Facility of the Year Award for Facility Integration for its Flexible Volume Manufacturing (FVM) Project in Research Triangle Park, North Carolina USA.
2. F. Hoffmann – La Roche, winner of the Facility of the Year Award for Project Execution for its TR&D – Building 98 Facility in Basel Switzerland.
3. MedImmune, winner of the Facility of the Year Award for Equipment Innovation for its UK Automation Upgrade Project in Speke, Liverpool UK
4. Merck & Co., Inc., winner of the Facility of the Year Award for Operational Excellence for its Vaccine and Biologics Sterile Facility (VBSF) Project in Carlow Ireland
5. Morphotek, Inc., winner of the Facility of the Year Award for Sustainability for its Morphotek Pilot Plant in Exton, Pennsylvania USA
6. Novartis Vaccines and Diagnostics, winner of the Facility of the Year Award for Process Innovation for its U.S. Flu Cell Culture Facility in Holly Springs, North Carolina USA
The Facility of the Year Awards Program is sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine. It is an annual program recognizing state-of-the-art pharmaceutical manufacturing projects that use innovative technologies to enhance the delivery of a superior project, as well as reduce the cost of producing high-quality medicines. Currently in its 9th year, the awards program recognizes the accomplishments, commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of all consumers.
For more information about the winning companies and their projects, visit www.FacilityoftheYear.org/FOYAWinners2013.
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
Biosimilars Market Prediction Up 20 Percent from 2012From Drug Store News
New report forecasts global $2.445 billion market this year
Cholesterol Drugs Could Help Kidney Cancer SurvivalFrom HealthDay News
Study finds statin medications tied to lower death risk after nearly four years of follow-up
Thermo Fisher Scientific Launches Online Configuration ToolFrom Thermo Fisher Scientific
iAutomate software reduces time needed for optimal system set-up design and provides accurate estimates
- All news »